Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Lack of Altered BECN1 Gene Expression in Iranian Patients with Acute Myeloid Leukemia

  • Keyvan, Ladan (Department of Genetic, South PNU Centre, Payame Noor University) ;
  • Bidoki, Seyed Kazem (Department of Genetics and Biotechnology, Payame Noor University) ;
  • Abdollahi, Davood Zare (Genetic Research Centre, University of Social Welfare and Rehabilitation Sciences) ;
  • Mansouri, Neda (Department of Medical Genetics, Shohada Cancer Research Center, School of Medicine, Shahid Beheshti University of Medical Science) ;
  • Hashemi, Mehrdad (Department of Molecular Genetics, Tehran Medical Sciences Branch, Islamic Azad University) ;
  • Tabatabaei, SA Mortazavi (Proteomics Research Center, School of Paramedical Sciences, Shahid Beheshti University of Medical Science) ;
  • Fardmanesh, Hediyeh (Molecular Medicine Research Center, Hormozgan University of Medical Sciences) ;
  • Meimandi, Mansour (Department of Periodontics, Phytochemistry Research Center, School of Pharmacy, Shahid Beheshti University of Medical Science) ;
  • Ayatollahi, Seyed Majid (Department of Periodontics, Phytochemistry Research Center, School of Pharmacy, Shahid Beheshti University of Medical Science) ;
  • Movafagh, Abolfazl (Department of Medical Genetics, Shohada Cancer Research Center, School of Medicine, Shahid Beheshti University of Medical Science)
  • Published : 2016.12.01
⟨ Previous Next ⟩

Abstract

Acute myeloid leukemia (AML), one of the most prevalent leukemia types in adults, demonstrates great heterogeneity in molecular and clinical terms. Hence, there is a necessity to the mechanisms involved in AML generation in order to determine optimal treatment. This cross sectional study aimed to assess changes in BECN1 gene expression in with blood samples from 30 AML patients, compared with samples from 15 healthy persons. RNA was extracted and cDNA was synthesized and Real Time PCR applied to determine BECN1 gene expression. The results showed no significant differences in BECN1 gene expression between patients with AML and normal controls (P > 0.05). It appears that expression of BECN1 does not play a significant role in genesis of AML leukemia.

Keywords

Acknowledgement

Supported by : Shahid Beheshti University of Medical Sciences

References

  1. Ahuja S, Koppenhagen K, Ernst H (1990). The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC). Strahlenther Onkol, 166, 718-21.
  2. Crazzolara R, Bradstock KF, Bendall LJ (2009). Everolimus induces autophagy in acute lymphoblastic leukemia. Autophagy, 5, 727-8. https://doi.org/10.4161/auto.5.5.8507
  3. Ding L, Xu Y, Wang LM, et al (2010). China non-communicable disease surveillance group. circulating microRNAs as novel diagnostic biomarkers for very early-onset ($\leq$40 years) coronary artery disease. Biomed Environ Sci, 29, 619-27.
  4. Emamalizadeh B, Movafagh A, Akbari M, et al (2014). RIT2, a susceptibility gene for Parkinson's disease in Iranian population. Neurobiol Aging, 35, 27-8.
  5. Falini B, Mecucci C, Tiacci E, et al (2005). Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med, 352, 254-66. https://doi.org/10.1056/NEJMoa041974
  6. Fu LL, Cheng Y, Liu B (2013). Beclin-1: autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol, 45, 921-4. https://doi.org/10.1016/j.biocel.2013.02.007
  7. Heidari MH, Porghasem M, Mirzaei N, et al (2014). The effect of high level natural ionizing radiation on expression of PSA, CA19-9 and CEA tumor markers in blood serum of inhabitants of Ramsar, Iran. J Environ Radioact, 128, 64-7. https://doi.org/10.1016/j.jenvrad.2013.11.001
  8. Huang W, Choi W, Hu W, et al (2012). Crystal structure and biochemical analyses reveal Beclin 1 as a novel membrane binding protein. Cell Res, 22, 473-89. https://doi.org/10.1038/cr.2012.24
  9. Kang R, Zeh HJ, Lotze MT, Tang D (2011). The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ, 18, 571-80. https://doi.org/10.1038/cdd.2010.191
  10. Kapoor V, Paliwal D, Singh SB, Mohanti BK, Das SN (2012). Deregulation of Beclin 1 in patients with tobacco-related oral squamous cell carcinoma. Biochem Biophys Res Commun, 422, 764-9. https://doi.org/10.1016/j.bbrc.2012.05.079
  11. Lankat-Buttgereit B, Goke R (2009). The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell, 101, 309-17. https://doi.org/10.1042/BC20080191
  12. Mourgues L, Imbert V, Nebout M, et al (2015). The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells. Leukemia, 29, 1993-2002. https://doi.org/10.1038/leu.2015.112
  13. Ozpolat B, Akar U, Steiner M, et al (2007). Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol Cancer Res, 5, 95-108. https://doi.org/10.1158/1541-7786.MCR-06-0125
  14. Li X, He L, Che KH, et al (2012). Imperfect interface of Beclin1 coiled-coil domain regulates homodimer and heterodimer formation with Atg14L and UVRAG. Nat Commun, 3, 662. https://doi.org/10.1038/ncomms1648
  15. Movafagh A, Hajifathali A, Isfahani F, et al (2012). Geographic heterogeneity of cytogenetic characteristics of acute myeloid leukemia in the early detection. Iran J Cancer Prev, 2, 85-9.
  16. Movafagh A, Mirfakhraei R, Mousavi-Jarrahi A (2011). Frequent incidence of double minute chromosomes in cancers, with special up-to-date reference to leukemia. Asian Pac J Cancer Prev, 12, 3453-6.
  17. Movafagh A, Hajifathali A, Zamani M (2011). Secondary chromosomal abnormalities of de novo acute myeloid leukemia-a first report from the Middle East. Asian Pac J Cancer Prev, 12, 2991-4.
  18. Movafagh A, Maleki F, Fadaei S, Azar E (2007). Persistent unstable chromosomal aberrations in lymphocytes of radiotherapy workers after 1st mitotic division in Tehran, Iran. Pak J Med Sci, 23, 254-8.
  19. Mori M, Takei S, Imagawa T, et al(2005). Pharmacokinetics, efficacy, and safety of short-term (12 weeks) etanercept for methotrexate-refractory polyarticular juvenile idiopathic arthritis in Japan. Mod Rheumatol, 15, 397-404. https://doi.org/10.3109/s10165-005-0431-9
  20. Seifi-Alan M, Shamsi R, Ghafouri-Fard S, et al (2014). Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines. Asian Pac J Cancer Prev. 14, 6625-9.
  21. Shargh SA, Sakizli M, Khalaj V, et al (2014). Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and itsrelation with progression and prognosis of tumor. Med Oncol, 31, 250. https://doi.org/10.1007/s12032-014-0250-y
  22. Wei L, Liu Y, Chen G, et al (2012). Differentiation of lymphatic endothelial cells from bone marrow mesenchymal stem cells with VEGFs. Lymphology, 45, 177-87.
  23. Zare-Abdollahi D, Safari S, Movafagh A, et al (2014). Intact expression status of RASSF1A in acute myeloid leukemia. Med Oncol, 31, 770. https://doi.org/10.1007/s12032-013-0770-x
  24. Zare-Abdollahi D, Safari S, Movafagh A, et al (2016). Expression analysis of BECN1 in acute myeloid leukemia: association with distinct cytogenetic and molecular abnormalities. Int J Lab Hematol, 38, 125-32. https://doi.org/10.1111/ijlh.12454